Mechanism of Salidroside in Tumor Suppression Through the MiRNA-mRNA Signaling Axis

Overview

Journal Zhong Nan Da Xue Xue Bao Yi Xue Ban

Specialty General Medicine

Date 2024 Aug 22

PMID 39174895

Authors

Xiaoxiong Wu

Zhendong Zhang

Xiaoping Wang

Affiliations

Soon will be listed here.

Abstract

With the rapid development of traditional Chinese medicine and the continuous discovery of various anticancer effects of salidroside (sal), it is known that sal inhibits tumor proliferation, invasion and migration by inducing apoptosis and autophagy, regulating the cell cycle, modulating the tumor microenvironment, and controlling cancer-related signaling pathways and molecules. The microRNA (miRNA)-mRNA signaling axis can regulate the expression of target mRNAs by altering miRNA expression, thereby affecting the growth cycle, proliferation, and metabolism of cancer cells. Studies have shown that sal can influence the occurrence and progression of various malignant tumors through the miRNA-mRNA signaling axis, inhibiting the progression of lung cancer, gastric cancer, and nasopharyngeal carcinoma, with a notable time and dose dependence in its antitumor effects. Summarizing the specific mechanism of sal regulating miRNA-mRNA signaling axis to inhibit tumors in recent years can provide a new theoretical basis, diagnosis, and therapeutic methods for the research on prevention and treatment of tumors.

References

Reddy K, Nabha S, Atanaskova N . Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev. 2003; 22(4):395-403. DOI: 10.1023/a:1023781114568. View

Liang M, Huang G, Liu Z, Wang Q, Yu Z, Liu Z . Elevated levels of hsa_circ_006100 in gastric cancer promote cell growth and metastasis via miR-195/GPRC5A signalling. Cell Prolif. 2019; 52(5):e12661. PMC: 6797516. DOI: 10.1111/cpr.12661. View

Song G, Ouyang G, Bao S . The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 2005; 9(1):59-71. PMC: 6741304. DOI: 10.1111/j.1582-4934.2005.tb00337.x. View

Marques M, Evangelista A, Macedo T, Vieira R, Scapulatempo-Neto C, Reis R . Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer. Clinics (Sao Paulo). 2018; 73:e184. PMC: 6024513. DOI: 10.6061/clinics/2018/e184. View

Anelli T, van Anken E . Missing links in antibody assembly control. Int J Cell Biol. 2014; 2013:606703. PMC: 3893805. DOI: 10.1155/2013/606703. View

Miller K, Fidler-Benaoudia M, Keegan T, Hipp H, Jemal A, Siegel R . Cancer statistics for adolescents and young adults, 2020. CA Cancer J Clin. 2020; 70(6):443-459. DOI: 10.3322/caac.21637. View

Bavelloni A, Ramazzotti G, Poli A, Piazzi M, Focaccia E, Blalock W . MiRNA-210: A Current Overview. Anticancer Res. 2017; 37(12):6511-6521. DOI: 10.21873/anticanres.12107. View

Karimi P, Islami F, Anandasabapathy S, Freedman N, Kamangar F . Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014; 23(5):700-13. PMC: 4019373. DOI: 10.1158/1055-9965.EPI-13-1057. View

Miller K, Siegel R, Lin C, Mariotto A, Kramer J, Rowland J . Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016; 66(4):271-89. DOI: 10.3322/caac.21349. View

10.

Wang Y, Zhou S, Yang F, Qi X, Wang X, Guan X . Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis. JAMA Oncol. 2019; 5(7):1008-1019. PMC: 6487913. DOI: 10.1001/jamaoncol.2019.0393. View

11.

Chen Y, Chan A, Le Q, Blanchard P, Sun Y, Ma J . Nasopharyngeal carcinoma. Lancet. 2019; 394(10192):64-80. DOI: 10.1016/S0140-6736(19)30956-0. View

12.

Ren M, Xu W, Xu T . Salidroside represses proliferation, migration and invasion of human lung cancer cells through AKT and MEK/ERK signal pathway. Artif Cells Nanomed Biotechnol. 2019; 47(1):1014-1021. DOI: 10.1080/21691401.2019.1584566. View

13.

Gao G, Guo X, Gu W, Lu Y, Chen Z . miRNA-142-3p functions as a potential tumor suppressor directly targeting FAM83D in the development of ovarian cancer. Aging (Albany NY). 2022; 14(8):3387-3399. PMC: 9085228. DOI: 10.18632/aging.203998. View

14.

Han L, Yin X, Zhang S . miR-103 promotes the metastasis and EMT of hepatocellular carcinoma by directly inhibiting LATS2. Int J Oncol. 2018; 53(6):2433-2444. PMC: 6203164. DOI: 10.3892/ijo.2018.4580. View

15.

Thai A, Solomon B, Sequist L, Gainor J, Heist R . Lung cancer. Lancet. 2021; 398(10299):535-554. DOI: 10.1016/S0140-6736(21)00312-3. View

16.

Wang Z, Li T, Chen M, Pan J, Shen K . miR-106b-5p contributes to the lung metastasis of breast cancer via targeting CNN1 and regulating Rho/ROCK1 pathway. Aging (Albany NY). 2020; 12(2):1867-1887. PMC: 7053600. DOI: 10.18632/aging.102719. View

17.

Long Z, Wang Y . miR-195-5p Suppresses Lung Cancer Cell Proliferation, Migration, and Invasion Via FOXK1. Technol Cancer Res Treat. 2020; 19:1533033820922587. PMC: 7238777. DOI: 10.1177/1533033820922587. View

18.

Zhang H, Jiang H, Zhang H, Liu J, Hu X, Chen L . miR-4262, low level of which predicts poor prognosis, targets proto-oncogene CD163 to suppress cell proliferation and invasion in gastric cancer. Onco Targets Ther. 2019; 12:599-607. PMC: 6339465. DOI: 10.2147/OTT.S187881. View

19.

Liu S, Li Y, Li Z . Salidroside suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis. Cell Cycle. 2022; 21(7):720-729. PMC: 8973335. DOI: 10.1080/15384101.2021.2019976. View

20.

OBrien J, Hayder H, Zayed Y, Peng C . Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne). 2018; 9:402. PMC: 6085463. DOI: 10.3389/fendo.2018.00402. View